key: cord-0860415-wloka49k authors: Kondo, Reiichiro; Kawaguchi, Nao; McConnell, Matthew J.; Sonzogni, Aurelio; Licini, Lisa; Valle, Clarissa; Bonaffini, Pietro A.; Sironi, Sandro; Alessio, Maria Grazia; Previtali, Giulia; Seghezzi, Michela; Zhang, Xuchen; Sun, Zhaoli; Utsumi, Teruo; Strazzabosco, Mario; Iwakiri, Yasuko title: Pathological characteristics of liver sinusoidal thrombosis in COVID‐19 patients: A series of 43 cases date: 2021-08-02 journal: Hepatol Res DOI: 10.1111/hepr.13696 sha: c292ad9ff694f8aac2abd9db28a9d99f92b85dbc doc_id: 860415 cord_uid: wloka49k AIM: Coronavirus disease (COVID‐19) is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) often correlates with disease severity in COVID‐19 patients. The aim of this study is to identify pathological microthrombi in COVID‐19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor (vWF) as mechanisms of their formation. METHODS: Forty‐three post‐mortem liver biopsy samples from COVID‐19 patients were obtained from Papa Giovanni XXIII Hospital in Bergamo, Italy. Three morphological features of microthrombosis (sinusoidal erythrocyte aggregation [SEA], platelet microthrombi [PMT], and fibrous thrombi) were evaluated. RESULTS: We found liver sinusoidal microthrombosis in 23 COVID‐19 patients (53%) was associated with a higher serum ALT and AST level compared to those without (ALT: 10‐fold, p = 0.04; AST: 11‐fold, p = 0.08). Of 43 livers, PMT and SEA were observed in 14 (33%) and 19 (44%) cases, respectively. Fibrous thrombi were not observed. Platelet microthrombi were associated with increased ALT (p < 0.01), whereas SEA was not (p = 0.73). In COVID‐19 livers, strong vWF staining in liver sinusoidal endothelial cells was associated with significantly increased platelet adhesion (1.7‐fold, p = 0.0016), compared to those with weak sinusoidal vWF (2‐fold, p < 0.0001). Sinusoidal erythrocyte aggregation in 19 (83%) liver samples was mainly seen in zone 2. Livers with SEA had significantly higher fibrinogen (1.6‐fold, p = 0.031) compared to those without SEA in COVID‐19 patients. CONCLUSIONS: Liver PMT is a pathologically important thrombosis associated with liver injury in COVID‐19, while SEA is a unique morphological feature of COVID‐19 patient livers. Sinusoidal vWF and hyperfibrinogenemia could contribute to PMT and SEA formation. Severe acute respiratory syndrome CoV-2 infection causes excessive levels of pro-inflammatory cytokines and pneumonia with secondary impacts on multiple organs, including the liver. Although respiratory failure is the primary cause of morbidity and mortality in COVID-19, liver injury (elevated serum ALT and AST) is common, and often correlates with severity of disease. 1 Tsutsumi et al. 2 reported that coagulopathy is associated with liver injury in patients with COVID-19. Several groups have reported liver sinusoidal microthrombosis with unique histological features in COVID-19 patients. [3] [4] [5] [6] Sonzogni et al. reported liver sinusoidal thrombosis in 13 of 48 patients with COVID-19 (27%). In this study, sinusoids with enlarged lumens occupied by erythrocytes mixed with lymphocytes and granulocytes were considered to have thrombosis (i.e. SEA). 3 Lagana et al. reported liver sinusoidal thrombosis with differing histology (fibrous thrombus) in 6 of 40 post-mortem liver tissues from COVID-19 patients (15%). 4 Zhao et al. reported a third morphology of liver sinusoidal thrombosis in 12 of 17 autopsy cases (70%) in COVID-19, CD61 + platelets aggregated in the sinusoids defined as PMT. 5 Similarly, the presence of PMT was reported in a liver biopsy from a living COVID-19 patient by Fiel et al. 6 Collectively, these studies showed the presence of sinusoidal microthrombi in 15%-70% of patients, leaving uncertainty about their true frequency and significance. Here we compare different morphologies of microthrombi (SEA, PMT, and fibrous thrombi) within one set of patients and correlate with liver injury. We also explore hyperfibrinogenemia and elevated vWF as mechanisms of microthrombosis in the liver. Post-mortem liver biopsy samples from COVID-19 patients were obtained from Drs. Aurelio Sonzogni and Lisa Licini from Papa Giovanni XXIII Hospital in Bergamo, Italy. As reported previously, 3 autopsies were performed after a median time of 6 h from death. Hematoxylin-eosin staining, PTAH staining, and immunohistochemical staining were carried out using paraffin-embedded liver specimens. For immunohistochemical staining, we used an automated immunostainer (intelliPATH FLX; Biocare Medical) and the following antibodies: polyclonal rabbit anti-human vWF antibody (A0082; dilution 1:4000; Dako), monoclonal mouse anti-human CD61 antibody (M0753; dilution 1:20; Dako), and polyclonal rabbit anti-human fibrinogen (ab34269; dilution 1:50; Abcam) (Table S1 ). Pathologists with experience in COVID-19 liver histopathology examined histological findings blindly (A.S. and R.K.). CD61 is a specific marker of platelets and megakaryocytes. In normal liver, some LSECs express vWF, and its intensity is weaker or comparable to those of vascular endothelial cells. 7 The vWF positive area and CD61 positive area in each specimen were measured in four randomly selected regions with �200 power field in an unbiased fashion using Fiji (ImageJ). The average number of neutrophils in the sinusoid at four randomly selected sinusoidal regions with �200 power field was evaluated to assess neutrophil accumulation in the sinusoids. We detected vWF, platelets, and fibrinogen by immunofluorescent labeling of paraffin-embedded human liver specimens. Paraffin sections were deparaffinized with xylene and dehydrated with graded ethanol. For immunofluorescence with vWF and CD41 (integrin αIIb), we undertook heat-induced epitope retrieval with citrate buffer (0.1 M citric acid and 0.1 M sodium citrate). CD41 is a specific marker of platelets and megakaryocytes. For immunofluorescence for fibrinogen, we used proteinase K-induced epitope retrieval. The sections were incubated with blocking buffer (5% normal donkey serum and 0.3% Triton X-100 in PBS) for 1 h and incubated with primary antibodies overnight at 4°C. The following antibodies were used: polyclonal rabbit anti-human vWF antibody (A0082, dilution 1:200; Dako), monoclonal mouse anti-human CD41 (integrin αIIb) antibody (sc-365938, dilution 1:100; Santa Cruz Biotechnology), and polyclonal rabbit anti-human fibrinogen antibody (A0080, dilution 1:100; Dako) (Table S1 ). After washing three times with PBS, each for 5 min, primary antibodies were detected using Alexa Fluor Fluoroshield containing DAPI (Sigma-Aldrich) and observed with a fluorescence microscope (Zeiss Observer Z1; Zeiss). The fibrinogen positive area in each specimen was measured in six randomly selected regions with �200 power field in an unbiased fashion using Fiji (ImageJ). All data are shown as the mean ± SEM. Statistical significance was determined by one-way ANOVA with Tukey's test or Welch's t-test as appropriate based on normality and variance. The χ 2 test was used for categorical variables. Statistical analysis was carried out using GraphPad Prism 9 (GraphPad) or the JMP software package (release 15.0; SAS Institute). Significance was defined as *p < 0.05, **p < 0.01, ***p < 0.001. For comparison to previous studies and utilizing hematoxylin−eosin and PTAH staining, we defined microthrombi containing predominantly erythrocytes as SEA (Figures 1a and S1 ) and microthrombi composed predominantly of fibrin as fibrous thrombi. Platelet microthrombi is defined as a predominance of aggregated platelets determined by immunolabeling with CD61 or CD41 (platelet markers) (Figures 1b, S2 and 3) . We found liver sinusoidal microthrombosis in 23 COVID-19 patients (53%) which was associated with a higher serum ALT and AST level compared to those without (ALT: 10-fold, p = 0.04, AST: 11-fold, p = 0.08) ( (Table 2) . Fibrous thrombi were not observed in our cases ( Figure S1 ). There was a significant increase in the presence of steatosis (p = 0.02) in livers with PMT and a trend toward increased presence of intrasinusoidal neutrophils in livers with PMT (p = 0.06) or SEA (p = 0.08), compared to control livers ( Table 2) . We have assessed whether demographic parameters could influence the occurrence of PMT or SEA (Table S2 ). The demographic parameters, including age, sex, diabetes, obesity, dyslipidemia, hypertension, intensive care unit admission, and DIC, did not significantly influence the presence of sinusoidal thrombosis, PMT, or SEA. However, these results could potentially be due to the small sample size available for the analysis of each parameter. Further analyses with a larger samples size could clarify these results. We found that PMT was associated with increased liver injury (p < 0.01), whereas SEA was not (p = 0.73) (Figure 1c ). Platelet microthrombi is also known to exist in other pathological conditions, including thrombotic microangiopathy, 8 chronic hepatitis/cirrhosis, 9 and SOS. 10 Platelet microthrombi formation in SOS depends on unusually large vWF multimer release from injured LSECs. 10 Hepatic steatosis with mild inflammatory infiltration has been also reported previously. 3, 11 Although the underlying mechanism remains unknown, we speculate that elevated IL-6 and the subsequent inflammatory signaling could mediate the induction of steatosis. The potential involvement of IL-6 signaling in the generation of steatosis can be suggested by the positive correlation between steatosis and PMT. Our very recent paper reported that IL-6 is capable of inducing endotheliopathy (pro-inflammatory and pro-coagulant states) in LSECs. 12 Given that PMT (platelet attachment, neutrophil recruitment, and fibrin deposition) is likely the result of endotheliopathy, PMT could be the result of IL-6 signaling. Further investigations will be needed to determine whether IL-6 directly or indirectly induces steatosis in COVID-19 patients. Sinusoidal erythrocyte aggregation is an aggregation of erythrocytes mixed with fibrin(ogen), leukocytes, and/or platelets, which attach to the surface of LSECs. We observed SEA in 19 (83%) of liver samples with sinusoidal microthrombosis, mainly located in zone 2 (Figures 1a, left panel, S4) . This is distinct from congestive hepatopathy, which is typically observed in zone 3. Generally, erythrocyte aggregation does not occur even in vascular congestion, because a net negative surface charge on erythrocytes by sialic acid prevents it. However, in the presence of macromolecules such as fibrinogen, which is known to interact with sialic acid on the surface of erythrocytes, erythrocytes aggregate (rouleaux formation). 13 (Figure 2b ). In conclusion, liver PMT is the most pathologically important morphology of microvascular thrombosis in COVID-19 because it is associated with liver injury. Platelet microthrombi potentially occurs due to strong expression of sinusoidal vWF. We propose that SEA is a unique morphological feature of COVID-19 livers due to hyperfibrinogenemia (Figure 2c ). This stands in contrast to patients with thrombotic microangiopathy or chronic hepatitis/ cirrhosis, in which unchanged or diminished fibrinogen production, respectively, is common. 8 The limitation of this study is its retrospective nature, meaning that variable factors including medical treatment, demographics among patients, timing of blood sample collection, and liver biopsy were not controlled. The serum AST and ALT values were obtained 6.3 days (average) before death. Thus, we cannot rule out the possibility that systemic circulatory disturbance before death may have affected the serum AST/ALT values. Although the thrombotic phenomena in the liver vasculature associated with liver injury in COVID-19 are generally not of significant concern in the acute setting, evidence from lung injury suggests the possibility of fibrosis or long-term consequences. Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1827 patients in a major U.S. hospital network Association of coagulopathy with liver dysfunction in patients with COVID-19 Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19) Findings of severe hepatic severe acute respiratory syndrome coronavirus-2 infection Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications Accumulation of platelets in the liver may be an important HEPATOLOGY contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C von Willebrand factor-rich platelet thrombi in the liver cause sinusoidal obstruction syndrome following oxaliplatin-based chemotherapy Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy Sublethal mechanical trauma alters the electrochemical properties and increases aggregation of erythrocytes High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients: A series of 43 cases The authors have no conflict of interest. https://orcid.org/0000-0003-2478-8878Pietro A. Bonaffini https://orcid.org/0000-0001-5335-9429Yasuko Iwakiri https://orcid.org/0000-0001-8032-5654